Benchmark, the aquaculture health, genetics and specialist nutrition business, experienced significant sales growth and earnings for the year ended Sept. 30, 2018.
In a trading update, the company said it is expecting revenues above £150 million (€171.9 million/$197.1 million) -- unaudited -- in 2018, up 7 percent from £140.2 million (€160.7 million/$184.3 million) in 2017.
Adjusted earnings before interest, tax, depreciation, amortization, exceptional items and acquisition related expenditure (Adjusted EBITDA) is expected to be above £16.5 million (€18.9 million/$21.7 million), a growth of 65 percent from £10 million (€11.5
